Extended therapy breaks from VEGFR TKI therapy in renal cell carcinoma: Sometimes less is more

Oncotarget. 2017 Dec 6;9(18):14036-14037. doi: 10.18632/oncotarget.23005. eCollection 2018 Mar 6.

Authors

Haris Zahoor¹, Brian I Rini¹, Moshe C Ornstein¹

Affiliation

¹ Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH.

No abstract available

Keywords: PD; TKI; VEGFR; intermittent; renal cell carcinoma.

Publication types

Editorial